A randomized, double-blinded placebo controlled trial to evaluate the efficacy of a multivitamin and mineral supplement to prevent infections in patients with inflammatory bowel disease.
Completed
- Conditions
- chronic bowel inflammationInflammatory bowel disease10017969
- Registration Number
- NL-OMON55309
- Lead Sponsor
- Sint Elisabeth Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 320
Inclusion Criteria
* Patients between the ages of 18 and 75 years old;
* Patients diagnosed with Crohn*s disease or Ulcerative Colitis;
* Patients using immunomodulators and/ or biologic therapy.
Exclusion Criteria
- patients with active inflammation;
- patients who has undergone surgical resection or are expected to require
during the stuy
- patients wo are pregnant or planning pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method